Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss of $1.15
Tweet
Share
E-mailGet Alerts MAZE Hot Sheet
Join SI Premium – FREE
Maze Therapeutics, Inc. (NASDAQ: MAZE) reported Q1 EPS of ($1.15).
For earnings history and earnings-related data on Maze Therapeutics, Inc. (MAZE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
